News

Ginkgo Technology Network brings together over 25 partners across an array of capabilities including AI, genetic medicines, biolog...

Team will present posters including 2 on ioCRISPR-Ready Cells & host an expert panel discussion on the important role of functiona...

Product will provide robust, standardised tool for study and screening of potential treatments for motor neuron diseases.

Minister Griffith cut the ribbon to officially open bit.bio’s manufacturing and automation labs for the consistent and scalable pr...

King's College London & bit.bio collaborate to develop multi-cell models of the human brain with optimised open-source protocols f...

Mark Kotter wins in two categories, Equity-Backed Entrepreneur of the Year and Purpose Entrepreneur of the Year, at the Great Brit...

Lead candidate is encapsulated allogeneic txHepatocytes for treatment of acute liver failure, SAB expanded to include 3 global exp...

bit.bio launches first product in groundbreaking ioCRISPR-Ready Cells™ product range, paving the way for new advances in disease m...